Rights and permissions
About this article
Cite this article
Adjunctive IL-3 has no impact on cost of autologous BMT. Inpharma Wkly. 1134, 7 (1998). https://doi.org/10.2165/00128413-199811340-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811340-00009